ALS: The Optimal Treatment Window May Open Earlier Than Expected
Physician's Weekly,
ATLAS trial will assess tofersen in pre-symptomatic SOD1 mutation…
Presymptomatic studies in ALS
Overview of attention for article published in Neurology, October 2012
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (88th percentile)
-
High Attention Score compared to outputs of the same age and source (82nd percentile)
Readers on
- mendeley
- 92 Mendeley